DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Alzheimer's disease	R-HSA-1643685	0	chlorcyclizine	3442	drug-path
Insulin signaling pathway	R-HSA-74752	map04910	chlorcyclizine	3442	drug-path
Huntington's disease	R-HSA-1643685	0	chlorcyclizine	3442	drug-path
Olfactory transduction	R-HSA-9751605	map04740	chlorcyclizine	3442	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	chlorcyclizine	3442	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	chlorcyclizine	3442	drug-path
Parkinson's disease	R-HSA-1643685	0	chlorcyclizine	3442	drug-path
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	chlorcyclizine	3442	drug-path
Natural killer cell mediated cytotoxicity	R-HSA-5218921	map04650	chlorcyclizine	3442	drug-path
Ribosome	R-HSA-5368277	map03010	chlorcyclizine	3442	drug-path
GnRH signaling pathway	R-HSA-168638	map04912	chlorcyclizine	3442	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	monobenzone	10154	drug-path
Cell cycle	R-HSA-1640170	map04110	monobenzone	10154	drug-path
p53 signaling pathway	R-HSA-168638	map04115	monobenzone	10154	drug-path
Non-homologous end-joining	R-HSA-5693571	map03450	monobenzone	10154	drug-path
Insulin signaling pathway	R-HSA-74752	map04910	pramocaine	4886	drug-path
Olfactory transduction	R-HSA-9751605	map04740	pramocaine	4886	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	pramocaine	4886	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	pramocaine	4886	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	pramocaine	4886	drug-path